CellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single‐Cell Multi‐Omics
Advanced Science · 2025
DOI: 10.1002/advs.202503289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Jade Young und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, CO, USA. Hauptthemen laut MEDLINE: Machine Learning, Single-Cell Analysis, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NLM NIH HHS, U.S. National Library of Medicine, Accelerating Medicines Partnership-Autoimmune and Immunologic Diseases Leadership Scholar Program.
Abstract (Originalsprache)
Single‐cell technologies have transformed the understanding of disease heterogeneity, but linking cell‐level phenotypic alterations to clinical outcomes becomes increasingly challenging as single‐cell datasets continue to expand. This is further complicated by the lack of interpretability in existing methods and the difficulty of detecting interaction effects—nonlinear dependencies between factors like sex, age, and disease. To address this, a novel explainable machine learning method, CellPhenoX, is developed to identify cell‐specific phenotypes and interaction effects linked to clinical outcomes. CellPhenoX integrates classification models, explainable artificial intelligence (AI) techniques, and a statistical framework to generate interpretable, cell‐specific scores to uncover condition‐associated cell populations. Extensive benchmarking and applications demonstrate the efficacy of CellPhenoX across diverse single‐cell study designs, including the dedicated and disease‐motivated simulations, binary disease‐control comparisons, and severity‐stratified patient cohorts. Notably, CellPhenoX identifies an activated monocyte phenotype in COVID‐19, with expansion correlated with disease severity after adjusting for covariates and interactive effects. It also uncovers a fibroblast‐specific state transition gradient predicting tissue inflammation in chronic diseases, and identifies therapy‐induced T cell changes and biomarkers linked to the tumor microenvironment. By integrating interpretability into clinical classification, CellPhenoX offers a powerful framework for translating single‐cell findings into clinical impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, CO, USA.
- Department of Medicine Rheumatology, University of Colorado School of Medicine, Aurora, CO, USA.
- Interdisciplinary Quantitative Biology PhD Program, BioFrontiers Institute, University of Colorado, Boulder, CO, USA.
ORCID-Profile: Jade Young, Fan Zhang
Förderung
- NLM NIH HHS
- U.S. National Library of Medicine
- Accelerating Medicines Partnership-Autoimmune and Immunologic Diseases Leadership Scholar Program
- NIAMS NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
Zitieren
APA
Young, J., Inamo, J., Caterer, Z., Krishna, R., & Zhang, F. (2025). CellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single‐Cell Multi‐Omics. Advanced Science. https://doi.org/10.1002/advs.202503289
Vancouver
Young J, Inamo J, Caterer Z, Krishna R, Zhang F. CellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single‐Cell Multi‐Omics. Advanced Science. 2025. doi:10.1002/advs.202503289
BibTeX
@article{Young2025,
author = {Young, Jade and Inamo, Jun and Caterer, Zachary and Krishna, Revanth and Zhang, Fan},
title = {CellPhenoX: An Explainable Machine Learning Method for Identifying Cell Phenotypes To Predict Clinical Outcomes from Single‐Cell Multi‐Omics},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202503289}
}
EUVIMED